All stock lists
Seaport Therapeutics, Inc. (NASDAQ:SPTX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
20.96+0.76 (+3.76%)
Market cap
$1.12B
Insider Score
Health Score
Analyst consensus
Listed since
May 1, 2026
Website
Insider Score
84/ 100
SPTX Insider Score
Bullish1 qualifying trade · 1 insider · $99.33K bought in the last 90 days
SPTX analyst forecast
SPTX analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
SPTX 12-month price target
$37.00+76.5% upsideaverage of 2 firms
$46.00High
$28.00Low
SPTX ratings mix, last 12 months
Buy Hold Sell
Best analysts covering SPTX
No firm covering SPTX has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
SPTX analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Seaport Global | — | $28.00 | +74.1% | — | 2026-10-14 | |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-10-08 |
| Seaport Global | — | $46.00 | +117.8% | — | 2026-09-25 | |
| Raymond James | — | $46.00 | +117.8% | — | 2026-09-25 | |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-09-10 |
| Seaport Global | — | $32.00 | +28.9% | — | 2026-08-25 | |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-08-20 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-08-04 |
SPTX earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-08-03 | -0.62 | -1.78 | $0 | $0 |
| 2026-11-02 | -0.57 | -0.49 | $0 | $0 |
| 2027-02-01Upcoming | -0.60 | — | $0 | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.